AGF Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.25M Sell
166,682
-17,333
-9% -$344K 0.01% 340
2026
Q1
$3.54M Buy
184,015
+24,171
+15% +$476K 0.02% 348
2025
Q4
$3.03M Buy
+159,844
New +$2.96M 0.01% 374
2024
Q4
– Sell
-185,298
Closed -$3.45M – 747
2024
Q3
$3.45M Buy
185,298
+21,853
+13% +$368K 0.02% 326
2024
Q2
$2.52M Sell
163,445
-492
-0.3% -$7.03K 0.01% 350
2024
Q1
$2.42M Buy
+163,937
New +$2.27M 0.01% 398
2023
Q3
– Sell
-329,022
Closed -$3.87M – 769
2023
Q2
$3.87M Buy
329,022
+48,507
+17% +$552K 0.03% 296
2023
Q1
$3.23M Buy
280,515
+12,002
+4% +$148K 0.02% 414
2022
Q4
$3.34M Buy
+268,513
New +$3.42M 0.02% 380

Other funds holding SBRA

AGF Management's SBRA Position: Q2 2026 in Review

AGF Management reduced its Sabra Healthcare REIT (SBRA) stake by 9.4% in Q2 2026, selling an estimated $344K and leaving 166,682 shares worth $3.25M. The position accounts for 0.01% of the portfolio, ranked #340.

AGF Management first reported a position in SBRA in Q4 2022 and has held it in 9 quarters since. The position peaked at $3.87M in Q2 2023. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • AGF Management held 166,682 shares of Sabra Healthcare REIT worth $3.25M as of Q2 2026.
  • AGF Management sold 17,333 Sabra Healthcare REIT shares in Q2 2026, an estimated $344K.
  • Sabra Healthcare REIT made up 0.01% of AGF Management's portfolio in Q2 2026, its #340 holding.
  • AGF Management first reported a position in Sabra Healthcare REIT in Q4 2022 and has held it in 9 quarters since.
  • AGF Management's Sabra Healthcare REIT position peaked at $3.87M in Q2 2023.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.